Madhav Vasanthavada - 20 Jan 2026 Form 4 Insider Report for ABEONA THERAPEUTICS INC. (ABEO)

Role: Chief Commercial Officer
Signature: /s/ Joseph Vazzano, as Attorney-in-fact
Issuer symbol: ABEO
Transactions as of: 20 Jan 2026
Net transactions value: -$66,658
Form type: 4
Filing time: 26 Jan 2026, 16:35:36 UTC
Previous filing: 26 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Vasanthavada Madhav	Chief Commercial Officer	6555 CARNEGIE AVE., 4TH FLOOR, CLEVELAND	/s/ Joseph Vazzano, as Attorney-in-fact	26 Jan 2026	0002106295

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABEO	Common Stock	Award	$0	+76,621	+30%	$0.000000	331,229	20 Jan 2026	Direct	F1
transaction	ABEO	Common Stock	Sale	$66,658	-12,610	-3.8%	$5.29	318,619	22 Jan 2026	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The restricted stock will vest one-third on each of January 20, 2027, January 20, 2028, and January 20, 2029
F2	The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards.
F3	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.28 to $5.35 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.